Synthetic mid-urethral sling complications: Evolution of presenting symptoms over time

Connie Wang, Alana L. Christie, Philippe E. Zimmern

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: To study the evolution of type of presenting symptoms after mid-urethral sling (MUS) placement relative to the interval between placement and subsequent synthetic sling removal (SSR) for complication(s). Methods: An IRB-approved, prospectively maintained database of women who underwent SSR was retrospectively reviewed for demographics, interval between MUS placement and SSR, history of chronic pain syndromes and recurrent urinary tract infections (RUTI), anti-incontinence and prolapse repairs, and MUS-related symptoms at presentation, including storage dysfunction, voiding dysfunction, RUTI, vaginal pain, non-vaginal pain, mesh exposure, and urinary incontinence (UI). Comparisons were made between patient groups divided into 2 and 4-year intervals to test the hypothesis that there would be higher rates of mesh exposure, pain and/or dyspareunia earlier, but higher rates of RUTI and UI in later groups. Results: Between 2005-2017, 278/435 women met study criteria. Overall, mean number of presenting symptoms per patient was 3.8±1.4 and increased significantly in relation to time since MUS placement (P<0.01). There was a significant difference between number of patients presenting with RUTI (P=0.01), vaginal pain (P=0.03), and UI (P=0.03) between the 2-year groups and a significant difference between number of patients presenting with RUTI (P<0.01), non-vaginal pain (P=0.01) and vaginal pain (P=0.05) between the 4-year groups. Conclusions: In our tertiary care center, women with MUS-related complications presented with multiple symptoms that increased in number over time, with a higher rate of pain complaints in earlier groups but a higher rate of RUTI and UI in later groups.

Original languageEnglish (US)
JournalNeurourology and Urodynamics
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Suburethral Slings
Urinary Tract Infections
Pain
Urinary Incontinence
Dyspareunia
Research Ethics Committees
Prolapse
Tertiary Care Centers
Chronic Pain
Demography
Databases

Keywords

  • Lower urinary tract symptoms
  • Mid-urethral sling
  • Synthetic sling complications

ASJC Scopus subject areas

  • Clinical Neurology
  • Urology

Cite this

Synthetic mid-urethral sling complications : Evolution of presenting symptoms over time. / Wang, Connie; Christie, Alana L.; Zimmern, Philippe E.

In: Neurourology and Urodynamics, 01.01.2018.

Research output: Contribution to journalArticle

@article{139c33bfb81348a99e9ca49b56ec6e60,
title = "Synthetic mid-urethral sling complications: Evolution of presenting symptoms over time",
abstract = "Introduction: To study the evolution of type of presenting symptoms after mid-urethral sling (MUS) placement relative to the interval between placement and subsequent synthetic sling removal (SSR) for complication(s). Methods: An IRB-approved, prospectively maintained database of women who underwent SSR was retrospectively reviewed for demographics, interval between MUS placement and SSR, history of chronic pain syndromes and recurrent urinary tract infections (RUTI), anti-incontinence and prolapse repairs, and MUS-related symptoms at presentation, including storage dysfunction, voiding dysfunction, RUTI, vaginal pain, non-vaginal pain, mesh exposure, and urinary incontinence (UI). Comparisons were made between patient groups divided into 2 and 4-year intervals to test the hypothesis that there would be higher rates of mesh exposure, pain and/or dyspareunia earlier, but higher rates of RUTI and UI in later groups. Results: Between 2005-2017, 278/435 women met study criteria. Overall, mean number of presenting symptoms per patient was 3.8±1.4 and increased significantly in relation to time since MUS placement (P<0.01). There was a significant difference between number of patients presenting with RUTI (P=0.01), vaginal pain (P=0.03), and UI (P=0.03) between the 2-year groups and a significant difference between number of patients presenting with RUTI (P<0.01), non-vaginal pain (P=0.01) and vaginal pain (P=0.05) between the 4-year groups. Conclusions: In our tertiary care center, women with MUS-related complications presented with multiple symptoms that increased in number over time, with a higher rate of pain complaints in earlier groups but a higher rate of RUTI and UI in later groups.",
keywords = "Lower urinary tract symptoms, Mid-urethral sling, Synthetic sling complications",
author = "Connie Wang and Christie, {Alana L.} and Zimmern, {Philippe E.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/nau.23534",
language = "English (US)",
journal = "Neurourology and Urodynamics",
issn = "0733-2467",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Synthetic mid-urethral sling complications

T2 - Evolution of presenting symptoms over time

AU - Wang, Connie

AU - Christie, Alana L.

AU - Zimmern, Philippe E.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: To study the evolution of type of presenting symptoms after mid-urethral sling (MUS) placement relative to the interval between placement and subsequent synthetic sling removal (SSR) for complication(s). Methods: An IRB-approved, prospectively maintained database of women who underwent SSR was retrospectively reviewed for demographics, interval between MUS placement and SSR, history of chronic pain syndromes and recurrent urinary tract infections (RUTI), anti-incontinence and prolapse repairs, and MUS-related symptoms at presentation, including storage dysfunction, voiding dysfunction, RUTI, vaginal pain, non-vaginal pain, mesh exposure, and urinary incontinence (UI). Comparisons were made between patient groups divided into 2 and 4-year intervals to test the hypothesis that there would be higher rates of mesh exposure, pain and/or dyspareunia earlier, but higher rates of RUTI and UI in later groups. Results: Between 2005-2017, 278/435 women met study criteria. Overall, mean number of presenting symptoms per patient was 3.8±1.4 and increased significantly in relation to time since MUS placement (P<0.01). There was a significant difference between number of patients presenting with RUTI (P=0.01), vaginal pain (P=0.03), and UI (P=0.03) between the 2-year groups and a significant difference between number of patients presenting with RUTI (P<0.01), non-vaginal pain (P=0.01) and vaginal pain (P=0.05) between the 4-year groups. Conclusions: In our tertiary care center, women with MUS-related complications presented with multiple symptoms that increased in number over time, with a higher rate of pain complaints in earlier groups but a higher rate of RUTI and UI in later groups.

AB - Introduction: To study the evolution of type of presenting symptoms after mid-urethral sling (MUS) placement relative to the interval between placement and subsequent synthetic sling removal (SSR) for complication(s). Methods: An IRB-approved, prospectively maintained database of women who underwent SSR was retrospectively reviewed for demographics, interval between MUS placement and SSR, history of chronic pain syndromes and recurrent urinary tract infections (RUTI), anti-incontinence and prolapse repairs, and MUS-related symptoms at presentation, including storage dysfunction, voiding dysfunction, RUTI, vaginal pain, non-vaginal pain, mesh exposure, and urinary incontinence (UI). Comparisons were made between patient groups divided into 2 and 4-year intervals to test the hypothesis that there would be higher rates of mesh exposure, pain and/or dyspareunia earlier, but higher rates of RUTI and UI in later groups. Results: Between 2005-2017, 278/435 women met study criteria. Overall, mean number of presenting symptoms per patient was 3.8±1.4 and increased significantly in relation to time since MUS placement (P<0.01). There was a significant difference between number of patients presenting with RUTI (P=0.01), vaginal pain (P=0.03), and UI (P=0.03) between the 2-year groups and a significant difference between number of patients presenting with RUTI (P<0.01), non-vaginal pain (P=0.01) and vaginal pain (P=0.05) between the 4-year groups. Conclusions: In our tertiary care center, women with MUS-related complications presented with multiple symptoms that increased in number over time, with a higher rate of pain complaints in earlier groups but a higher rate of RUTI and UI in later groups.

KW - Lower urinary tract symptoms

KW - Mid-urethral sling

KW - Synthetic sling complications

UR - http://www.scopus.com/inward/record.url?scp=85042199865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042199865&partnerID=8YFLogxK

U2 - 10.1002/nau.23534

DO - 10.1002/nau.23534

M3 - Article

C2 - 29464783

AN - SCOPUS:85042199865

JO - Neurourology and Urodynamics

JF - Neurourology and Urodynamics

SN - 0733-2467

ER -